SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

FATE

Fate Therapeutics Inc.
NASDAQHealth Care

Latest close: 1.79 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 28, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 13, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record78916 flagged findings
Reported transactions (Form 4)80since Dec 18, 2023 · and 10 other holdings
Corporate events (8-K)30since Jun 10, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

What the company does

a clinical-stage biopharmaceutical company in San Diego, United States

Source: Wikidata (CC0 1.0) · copied on Sep 3, 2026 · may not reflect recent changes.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-13share offering or dilution eventrecentOpen filing ↗
    “…to be classified in equity), the Company recorded the consideration received from the issuance of the warrants as additional…”
    +1 more passage from the same document
    • “…time. The specific terms of any offering under the shelf registration statement would be established at the time of such offering.…”
  • 2026-05-13listing compliance noticerecentOpen filing ↗
    “…average common stock price exceeded the first, pre-specified threshold. Accordingly, MSKCC received the first milestone…”
    +1 more passage from the same document
    • “…stock is currently listed on the Nasdaq Global Market (Nasdaq), which has minimum requirements that a company must meet in order to…”
  • 2026-02-26share offering or dilution eventrecentOpen filing ↗
    “…to be classified in equity), the Company recorded the consideration received from the issuance of the warrants as additional…”
    +1 more passage from the same document
    • “…time. The specific terms of any offering under the shelf registration statement would be established at the time of such offering.…”
  • 2026-02-26listing compliance noticerecentOpen filing ↗
    “…average common stock price exceeded the first, pre-specified threshold. Accordingly, MSKCC received the first milestone payment…”
    +1 more passage from the same document
    • “…stock is currently listed on the Nasdaq Global Market (Nasdaq), which has minimum requirements that a company must meet in order to…”
  • 2026-02-26capital return (buybacks/dividends)recentOpen filing ↗
    “…incorporated herein by reference to Item 12 of Part III of this Annual Report. Recent Sales of Unregistered Securities During the…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 789)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Sep 28, 268-K ↗Current report · Other events
  • Aug 13, 2610-Q ↗Quarterly report
  • Aug 13, 268-K ↗Current report · Results
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Jul 8, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 1.9% · event on Jun 30, 26 · amendment
  • Insider transaction · 7 Form 4 filingsshow all 7hide
  • Jun 15, 26Form 3 ↗Insider transaction
  • Jun 15, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Jun 4, 268-K ↗Current report · Other events
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • May 13, 2610-Q ↗Quarterly report

789 filings on record, the oldest from Jul 17, 13.

Listing the 25 most recent filings of the 789 on record.

8-Ks, explained

Stress3Structure38Governance29
  • Jun 15, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Oct 14, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Aug 12, 25StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Governance3 senior executive changes2024 – 2025show all 3hide
    • May 30, 25GovernanceA senior executive left or was appointed+4 more in the same filing8-K 5.02 ↗
    • Jan 6, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Nov 29, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Aug 30, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2024show all 3hide
    • Jul 31, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Jun 7, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 31, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 21, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Nov 8, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 8, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 19, 23StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Jan 5, 23StressRestructuring plan with committed costs+4 more in the same filing8-K 2.05 ↗
  • Nov 7, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

8 older filings not shown · The record reaches back to Jan 10, 14.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Redmile Group, LLC14.9%Apr 20, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • The Vanguard Group7.6%Jun 30, 25SCHEDULE 13G/A ↗
  • THE GOLDMAN SACHS GROUP, INC.2.0%Jun 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • BlackRock, Inc.1.9%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
  • Schonfeld Strategic Advisors LLC0.8%Jun 30, 25SCHEDULE 13G/A ↗1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 4, TAHL CINDY filed notice of intent to sell up to $95K. That is about 0.03% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $95K on Aug 4, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+1 more recent notices · 1 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 4, 26Sell$108KBahram ValamehrPresident and CEO↗
  • Aug 4, 26Sell$95KCINDY TAHLSee Remarks↗
  • May 20, 26Sell$54KBahram ValamehrPresident and CEO↗
  • May 20, 26Sell$48KCINDY TAHLSee Remarks↗
  • Jan 9, 26Sell$6KBahram ValamehrPresident and CEO↗
  • Jan 9, 26Sell$11KCINDY TAHLSee Remarks↗
  • Aug 4, 25Sell$15KBahram ValamehrPresident and CEO↗
  • Aug 4, 25Sell$10KCINDY TAHLSee Remarks↗
  • Jan 10, 25Sell$13KBahram ValamehrPresident and CEO↗
  • Jan 10, 25Sell$9KCINDY TAHLSee Remarks↗
  • Jan 10, 25Sell$9KJerome Charles BressiSee Remarks↗
  • Dec 20, 24Sell$574KRedmile Group, LLC↗

There are 11 more transactions in this stretch.

Stock compensation, tax and giftsshow the 17 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • May 6, 26Compensation$161KCINDY TAHLSee Remarks↗
  • May 6, 26Compensation$47KCINDY TAHLSee Remarks↗
  • May 5, 26Compensation$42KWILLIAM H RASTETTER↗
  • May 5, 26Compensation$42KROBERT S EPSTEIN↗
  • Apr 20, 26Otheramount n/aRedmile Group, LLC↗
  • Jan 15, 26Compensationamount n/aBahram ValamehrPresident and CEO↗
  • Jan 15, 26Compensationamount n/aKamal AdawiChief Financial Officer↗
  • Jan 15, 26Compensationamount n/aCINDY TAHLSee Remarks↗
  • Oct 20, 25Compensationamount n/aKamal AdawiChief Financial Officer↗
  • Jan 15, 25Compensationamount n/aJerome Charles BressiSee Remarks↗
  • Jan 15, 25Compensationamount n/aCINDY TAHLSee Remarks↗
  • Dec 20, 24Other$1.8MRedmile Group, LLC↗
  • Dec 20, 24Other$1.8MRedmile Group, LLC↗
  • Dec 12, 24Otheramount n/aRedmile Group, LLC↗
  • Jul 29, 24Compensationamount n/aCINDY TAHLGeneral Counsel and Secretary↗
  • Jul 29, 24Compensationamount n/aBahram ValamehrChief R&D Officer↗
  • Dec 26, 23Other$6.2MRedmile Group, LLC↗

The full record holds 64 transactions and goes back to Jan 10, 23.

Its sector and its market

Fate Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Fate Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Fate Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
789 documents on file, from Jul 17, 2013 to Sep 28, 2026.
Company description
Wikidata, read on Sep 3, 2026.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.